ANRO
Alto Neuroscience, Inc. · Healthcare · Biotechnology
Input di momentum (manager comparabili):
ampiezza dei detentori +4.3% ·
flusso azionario +9.9% ·
nuove posizioni nette +4.2%
— formula
Accumulo diffuso — azioni in aumento tra un maggior numero di detentori
Tutte le cifre di proprietà: solo gestori 13F monitorati, posizioni in azioni ordinarie, periodo di riferimento Q4 2025
| Trimestre | Detentori | Δ | Quote | Valore dichiarato | Nuovo | Uscite |
|---|---|---|---|---|---|---|
| Q2 2026 | 56 | +2 | 11.54M | $304.54M | +10 | −8 |
| Q1 2026 | 55 | +7 | 8.39M | $188.63M | +8 | −1 |
| Q4 2025 | 48 | +2 | 8.42M | $149.83M | +3 | −1 |
| Q3 2025 | 15 | +1 | 4.77M | $19.16M | +1 | — |
| Q2 2025 | 12 | 0 | 4.77M | $10.50M | +1 | −1 |
| Q1 2025 | 9 | +1 | 3.54M | $7.65M | +2 | −1 |
| Q4 2024 | 8 | +2 | 5.27M | $22.30M | +2 | — |
| Q3 2024 | 5 | 0 | 2.33M | $26.66M | +2 | −2 |
| Q2 2024 | 5 | — | 1.98M | $21.15M | — | — |
| # | Gestore | Quote | Δ azioni | Valore | Il loro peso | Detenuto | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Point72 Asset Management ✦ | 1.61M | +20.6% | $28.60M | 0.0% | ▲ Add | 7 | SEC ↗ |
| 2 | The Vanguard Group ✦ (passivo) | 1.37M | +23.6% | $24.31M | 0.0% | ▲ Add | 3 | SEC ↗ ×3 |
| 3 | Franklin Resources Inc | 1.12M | — | $19.93M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Millennium Management ✦ | 629.99K | +99.5% | $11.21M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 5 | BlackRock ✦ (passivo) | 607.87K | +65.2% | $10.82M | 0.0% | ▲ Add | 3 | SEC ↗ ×4 |
| 6 | Alkeon Capital Management Llc | 477.10K | — | $8.49M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | Northern Trust Corp | 474.37K | — | $8.44M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | Geode Capital Management ✦ (passivo) | 287.44K | +20.8% | $5.12M | 0.0% | ▲ Add | 7 | SEC ↗ ×2 |
| 9 | Jane Street Group, Llc | 194.04K | — | $3.45M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 10 | Marshall Wace ✦ | 193.11K | -76.6% | $3.44M | 0.0% | ▼ Trim | 5 | SEC ↗ ×3 |
| 11 | Goldman Sachs Group ✦ | 156.32K | +73.2% | $2.78M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 12 | Two Sigma Investments ✦ | 140.32K | +20.4% | $2.50M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 13 | State Street Global Advisors ✦ (passivo) | 130.66K | +26.6% | $2.33M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 14 | D. E. Shaw & Co. ✦ | 124.80K | Nuovo | $2.22M | 0.0% | New | 1 | SEC ↗ |
| 15 | Susquehanna International Group, Llp | 118.16K | — | $2.10M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | Qube Research & Technologies Ltd | 112.79K | — | $2.01M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | Renaissance Technologies ✦ | 97.40K | +28.5% | $1.73M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 18 | Stifel Financial Corp | 87.16K | — | $1.55M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | Wellington Management ✦ | 69.02K | Nuovo | $1.23M | 0.0% | New | 1 | SEC ↗ ×3 |
| 20 | Morgan Stanley ✦ | 65.58K | +7.5% | $1.17M | 0.0% | ▲ Add | 2 | SEC ↗ ×6 |
| 21 | Allianz Asset Management GmbH | 43.00K | — | $765,400 | 0.0% | n/c | 1 | SEC ↗ |
| 22 | Quantinno Capital Management LP | 35.58K | — | $633,306 | 0.0% | n/c | 1 | SEC ↗ |
| 23 | Bnp Paribas Financial Markets | 33.23K | — | $591,583 | 0.0% | n/c | 1 | SEC ↗ |
| 24 | Dimensional Fund Advisors Lp | 31.18K | — | $554,933 | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 25 | Barclays Plc | 30.39K | — | $540,978 | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 26 | T. Rowe Price ✦ | 30.23K | -49.1% | $539,000 | 0.0% | ▼ Trim | 7 | SEC ↗ |
| 27 | Brown Advisory Inc | 25.00K | — | $445,000 | 0.0% | n/c | 1 | SEC ↗ |
| 28 | UBS Group AG | 18.49K | — | $329,104 | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 29 | Charles Schwab Investment… | 17.06K | — | $303,739 | 0.0% | n/c | 1 | SEC ↗ |
| 30 | Ameriprise Financial Inc | 13.49K | — | $240,069 | 0.0% | n/c | 1 | SEC ↗ |
| 31 | Citadel Advisors ✦ | 12.97K | -65.1% | $230,919 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 32 | Citigroup Inc | 12.57K | — | $223,675 | 0.0% | n/c | 1 | SEC ↗ |
| 33 | Bank Of Montreal /Can/ | 11.36K | — | $202,119 | 0.0% | n/c | 1 | SEC ↗ |
| 34 | Balyasny Asset Management L.P. | 11.12K | — | $197,936 | 0.0% | n/c | 1 | SEC ↗ |
| 35 | Bank Of America Corp /De/ | 11.09K | — | $197,437 | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 36 | American Century Companies Inc | 10.36K | — | $184,408 | 0.0% | n/c | 1 | SEC ↗ |
| 37 | Fidelity (FMR) ✦ | 6.37K | -17.0% | $113,457 | 0.0% | ▼ Trim | 3 | SEC ↗ ×2 |
| 38 | Group One Trading Llc | 1.41K | — | $25,151 | 0.0% | n/c | 1 | SEC ↗ |
| 39 | Pnc Financial Services Group, Inc. | 1.31K | — | $23,265 | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 40 | Federated Hermes, Inc. | 770 | — | $13,706 | 0.0% | n/c | 1 | SEC ↗ |
| 41 | Wells Fargo & Company/Mn | 765 | — | $13,617 | 0.0% | n/c | 1 | SEC ↗ |
| 42 | Russell Investments Group, Ltd. | 306 | — | $5,447 | 0.0% | n/c | 1 | SEC ↗ |
| 43 | Cwm, Llc | 154 | — | $3,000 | 0.0% | n/c | 1 | SEC ↗ |
| 44 | JPMorgan Chase ✦ | 146 | Nuovo | $2,599 | 0.0% | New | 1 | SEC ↗ |
| 45 | Us Bancorp \De\ | 113 | — | $2,011 | 0.0% | n/c | 1 | SEC ↗ |
| 46 | Royal Bank Of Canada | 34 | — | $1,000 | 0.0% | n/c | 1 | SEC ↗ |
| 47 | Jones Financial Companies Lllp | 33 | — | $587 | 0.0% | n/c | 1 | SEC ↗ |
| 48 | Optiver Holding B.V. | 20 | — | $356 | 0.0% | n/c | 1 | SEC ↗ |
"Il loro peso" = la quota della posizione sul valore azionario 13F dichiarato da quel gestore — la misura di convinzione. ✦ = gestore selezionato.
Nuovi acquirenti
| D. E. Shaw & Co. | $2.22M | 0.0% |
| Wellington Management | $1.23M | 0.0% |
| JPMorgan Chase | $2,599 | 0.0% |
Uscito
| AQR Capital Management | $122,256 | era 0.0% |
Contesto di mercato completo: su TUTTI i filer 13F (dati strutturati SEC, Q1 2026): 108 detentori, 26.83M azioni, $592.78M dichiarato. Questo è un periodo diverso e più vecchio rispetto ai dati dell'universo monitorato riportati sopra e i due non vengono mai combinati.
Cosa detengono più spesso gli altri holder monitorati di questo titolo — conteggi di proprietà condivisa, non relazioni fondamentali.
Acquisti sul mercato aperto (P)
Nessun acquisto insider sul mercato aperto nella nostra finestra di copertura.
Vendite sul mercato aperto (S)
Officer · 23.17K az. · $597,290
Officer · 886 az. · $23,807
Officer · 110.83K az. · $2.95M
Assegnazioni, esercizi e ritenute fiscali non vengono mai conteggiati come acquisti o vendite in questa sede. Metodologia